世界の小児インフルエンザ治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pediatric Influenza Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4674
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、小児インフルエンザ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗ウイルス薬、解熱剤、ノイラミニダーゼ阻害剤、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・小児インフルエンザ治療の市場動向
・企業の競争状況、市場シェア
・小児インフルエンザ治療の種類別市場規模と予測2016-2027（抗ウイルス薬、解熱剤、ノイラミニダーゼ阻害剤、その他）
・小児インフルエンザ治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他）
・小児インフルエンザ治療の北米市場規模2016-2027（アメリカ、カナダ）
・小児インフルエンザ治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・小児インフルエンザ治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・小児インフルエンザ治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・小児インフルエンザ治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc.、NATCO Pharma Limited.、NESHER PHARMS、Johnson & Johnsons Inc.、Cipla、Hetero Pharma、Teva Pharmaceutical pvt. Ltd.、Olainfarm JSC、Gilead Sciences, Inc.）
・結論

Most kids are enrolled in early education and child care programs. Seasonal influenza outbreaks are expected annually. Influenza can be severe, resulting in hospitalization or death of some children. Immunization against influenza is the best strategy to reduce infection and spread.

Market Analysis and Insights: Global Pediatric Influenza Treatment Market
The global Pediatric Influenza Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Influenza Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Influenza Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Influenza Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Influenza Treatment market.

Global Pediatric Influenza Treatment Scope and Market Size
Pediatric Influenza Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Influenza Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antiviral Drug
Antipyretic
Neuraminidase inhibitor
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Influenza Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antiviral Drug
1.2.3 Antipyretic
1.2.4 Neuraminidase inhibitor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pediatric Influenza Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Influenza Treatment Market Perspective (2016-2027)
2.2 Pediatric Influenza Treatment Growth Trends by Regions
2.2.1 Pediatric Influenza Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediatric Influenza Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pediatric Influenza Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pediatric Influenza Treatment Industry Dynamic
2.3.1 Pediatric Influenza Treatment Market Trends
2.3.2 Pediatric Influenza Treatment Market Drivers
2.3.3 Pediatric Influenza Treatment Market Challenges
2.3.4 Pediatric Influenza Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Influenza Treatment Players by Revenue
3.1.1 Global Top Pediatric Influenza Treatment Players by Revenue (2016-2021)
3.1.2 Global Pediatric Influenza Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediatric Influenza Treatment Revenue
3.4 Global Pediatric Influenza Treatment Market Concentration Ratio
3.4.1 Global Pediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Influenza Treatment Revenue in 2020
3.5 Pediatric Influenza Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Influenza Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Influenza Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Influenza Treatment Breakdown Data by Type
4.1 Global Pediatric Influenza Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pediatric Influenza Treatment Forecasted Market Size by Type (2022-2027)

5 Pediatric Influenza Treatment Breakdown Data by Application
5.1 Global Pediatric Influenza Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pediatric Influenza Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediatric Influenza Treatment Market Size (2016-2027)
6.2 North America Pediatric Influenza Treatment Market Size by Type
6.2.1 North America Pediatric Influenza Treatment Market Size by Type (2016-2021)
6.2.2 North America Pediatric Influenza Treatment Market Size by Type (2022-2027)
6.2.3 North America Pediatric Influenza Treatment Market Size by Type (2016-2027)
6.3 North America Pediatric Influenza Treatment Market Size by Application
6.3.1 North America Pediatric Influenza Treatment Market Size by Application (2016-2021)
6.3.2 North America Pediatric Influenza Treatment Market Size by Application (2022-2027)
6.3.3 North America Pediatric Influenza Treatment Market Size by Application (2016-2027)
6.4 North America Pediatric Influenza Treatment Market Size by Country
6.4.1 North America Pediatric Influenza Treatment Market Size by Country (2016-2021)
6.4.2 North America Pediatric Influenza Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pediatric Influenza Treatment Market Size (2016-2027)
7.2 Europe Pediatric Influenza Treatment Market Size by Type
7.2.1 Europe Pediatric Influenza Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pediatric Influenza Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pediatric Influenza Treatment Market Size by Type (2016-2027)
7.3 Europe Pediatric Influenza Treatment Market Size by Application
7.3.1 Europe Pediatric Influenza Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pediatric Influenza Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pediatric Influenza Treatment Market Size by Application (2016-2027)
7.4 Europe Pediatric Influenza Treatment Market Size by Country
7.4.1 Europe Pediatric Influenza Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pediatric Influenza Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediatric Influenza Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Type
8.2.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Application
8.3.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediatric Influenza Treatment Market Size by Region
8.4.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediatric Influenza Treatment Market Size (2016-2027)
9.2 Latin America Pediatric Influenza Treatment Market Size by Type
9.2.1 Latin America Pediatric Influenza Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pediatric Influenza Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pediatric Influenza Treatment Market Size by Type (2016-2027)
9.3 Latin America Pediatric Influenza Treatment Market Size by Application
9.3.1 Latin America Pediatric Influenza Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pediatric Influenza Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pediatric Influenza Treatment Market Size by Application (2016-2027)
9.4 Latin America Pediatric Influenza Treatment Market Size by Country
9.4.1 Latin America Pediatric Influenza Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pediatric Influenza Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediatric Influenza Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Type
10.2.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Application
10.3.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediatric Influenza Treatment Market Size by Country
10.4.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 GlaxoSmithKline Plc.
11.2.1 GlaxoSmithKline Plc. Company Details
11.2.2 GlaxoSmithKline Plc. Business Overview
11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Introduction
11.2.4 GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Plc. Recent Development
11.3 NATCO Pharma Limited.
11.3.1 NATCO Pharma Limited. Company Details
11.3.2 NATCO Pharma Limited. Business Overview
11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Introduction
11.3.4 NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.3.5 NATCO Pharma Limited. Recent Development
11.4 NESHER PHARMS
11.4.1 NESHER PHARMS Company Details
11.4.2 NESHER PHARMS Business Overview
11.4.3 NESHER PHARMS Pediatric Influenza Treatment Introduction
11.4.4 NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.4.5 NESHER PHARMS Recent Development
11.5 Johnson & Johnsons Inc.
11.5.1 Johnson & Johnsons Inc. Company Details
11.5.2 Johnson & Johnsons Inc. Business Overview
11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Introduction
11.5.4 Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.5.5 Johnson & Johnsons Inc. Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Pediatric Influenza Treatment Introduction
11.6.4 Cipla Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Hetero Pharma
11.7.1 Hetero Pharma Company Details
11.7.2 Hetero Pharma Business Overview
11.7.3 Hetero Pharma Pediatric Influenza Treatment Introduction
11.7.4 Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.7.5 Hetero Pharma Recent Development
11.8 Teva Pharmaceutical pvt. Ltd.
11.8.1 Teva Pharmaceutical pvt. Ltd. Company Details
11.8.2 Teva Pharmaceutical pvt. Ltd. Business Overview
11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Introduction
11.8.4 Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical pvt. Ltd. Recent Development
11.9 Olainfarm JSC
11.9.1 Olainfarm JSC Company Details
11.9.2 Olainfarm JSC Business Overview
11.9.3 Olainfarm JSC Pediatric Influenza Treatment Introduction
11.9.4 Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.9.5 Olainfarm JSC Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.10.5 Gilead Sciences, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antiviral Drug
Table 3. Key Players of Antipyretic
Table 4. Key Players of Neuraminidase inhibitor
Table 5. Key Players of Others
Table 6. Global Pediatric Influenza Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pediatric Influenza Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pediatric Influenza Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pediatric Influenza Treatment Market Share by Regions (2016-2021)
Table 10. Global Pediatric Influenza Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pediatric Influenza Treatment Market Share by Regions (2022-2027)
Table 12. Pediatric Influenza Treatment Market Trends
Table 13. Pediatric Influenza Treatment Market Drivers
Table 14. Pediatric Influenza Treatment Market Challenges
Table 15. Pediatric Influenza Treatment Market Restraints
Table 16. Global Pediatric Influenza Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pediatric Influenza Treatment Market Share by Players (2016-2021)
Table 18. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Influenza Treatment as of 2020)
Table 19. Ranking of Global Top Pediatric Influenza Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pediatric Influenza Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pediatric Influenza Treatment Product Solution and Service
Table 23. Date of Enter into Pediatric Influenza Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Influenza Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pediatric Influenza Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Pediatric Influenza Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pediatric Influenza Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pediatric Influenza Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pediatric Influenza Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Pediatric Influenza Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pediatric Influenza Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pediatric Influenza Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pediatric Influenza Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pediatric Influenza Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pediatric Influenza Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pediatric Influenza Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pediatric Influenza Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pediatric Influenza Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pediatric Influenza Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pediatric Influenza Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pediatric Influenza Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pediatric Influenza Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pediatric Influenza Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pediatric Influenza Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pediatric Influenza Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pediatric Influenza Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pediatric Influenza Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pediatric Influenza Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pediatric Influenza Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. F. Hoffmann-La Roche Ltd Company Details
Table 64. F. Hoffmann-La Roche Ltd Business Overview
Table 65. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product
Table 66. F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 67. F. Hoffmann-La Roche Ltd Recent Development
Table 68. GlaxoSmithKline Plc. Company Details
Table 69. GlaxoSmithKline Plc. Business Overview
Table 70. GlaxoSmithKline Plc. Pediatric Influenza Treatment Product
Table 71. GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Plc. Recent Development
Table 73. NATCO Pharma Limited. Company Details
Table 74. NATCO Pharma Limited. Business Overview
Table 75. NATCO Pharma Limited. Pediatric Influenza Treatment Product
Table 76. NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 77. NATCO Pharma Limited. Recent Development
Table 78. NESHER PHARMS Company Details
Table 79. NESHER PHARMS Business Overview
Table 80. NESHER PHARMS Pediatric Influenza Treatment Product
Table 81. NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 82. NESHER PHARMS Recent Development
Table 83. Johnson & Johnsons Inc. Company Details
Table 84. Johnson & Johnsons Inc. Business Overview
Table 85. Johnson & Johnsons Inc. Pediatric Influenza Treatment Product
Table 86. Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnsons Inc. Recent Development
Table 88. Cipla Company Details
Table 89. Cipla Business Overview
Table 90. Cipla Pediatric Influenza Treatment Product
Table 91. Cipla Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 92. Cipla Recent Development
Table 93. Hetero Pharma Company Details
Table 94. Hetero Pharma Business Overview
Table 95. Hetero Pharma Pediatric Influenza Treatment Product
Table 96. Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 97. Hetero Pharma Recent Development
Table 98. Teva Pharmaceutical pvt. Ltd. Company Details
Table 99. Teva Pharmaceutical pvt. Ltd. Business Overview
Table 100. Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 101. Teva Pharmaceutical pvt. Ltd. Recent Development
Table 102. Olainfarm JSC Company Details
Table 103. Olainfarm JSC Business Overview
Table 104. Olainfarm JSC Pediatric Influenza Treatment Product
Table 105. Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 106. Olainfarm JSC Recent Development
Table 107. Gilead Sciences, Inc. Company Details
Table 108. Gilead Sciences, Inc. Business Overview
Table 109. Gilead Sciences, Inc. Pediatric Influenza Treatment Product
Table 110. Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2016-2021) & (US$ Million)
Table 111. Gilead Sciences, Inc. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Influenza Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antiviral Drug Features
Figure 3. Antipyretic Features
Figure 4. Neuraminidase inhibitor Features
Figure 5. Others Features
Figure 6. Global Pediatric Influenza Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Pediatric Influenza Treatment Report Years Considered
Figure 12. Global Pediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pediatric Influenza Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pediatric Influenza Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Pediatric Influenza Treatment Market Share by Regions (2022-2027)
Figure 16. Global Pediatric Influenza Treatment Market Share by Players in 2020
Figure 17. Global Top Pediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Influenza Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pediatric Influenza Treatment Revenue in 2020
Figure 19. Global Pediatric Influenza Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Pediatric Influenza Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pediatric Influenza Treatment Market Share by Type (2016-2027)
Figure 23. North America Pediatric Influenza Treatment Market Share by Application (2016-2027)
Figure 24. North America Pediatric Influenza Treatment Market Share by Country (2016-2027)
Figure 25. United States Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pediatric Influenza Treatment Market Share by Type (2016-2027)
Figure 29. Europe Pediatric Influenza Treatment Market Share by Application (2016-2027)
Figure 30. Europe Pediatric Influenza Treatment Market Share by Country (2016-2027)
Figure 31. Germany Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pediatric Influenza Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pediatric Influenza Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pediatric Influenza Treatment Market Share by Region (2016-2027)
Figure 41. China Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pediatric Influenza Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Pediatric Influenza Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Pediatric Influenza Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pediatric Influenza Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pediatric Influenza Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pediatric Influenza Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pediatric Influenza Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline Plc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 62. NATCO Pharma Limited. Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 63. NESHER PHARMS Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 64. Johnson & Johnsons Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 65. Cipla Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 66. Hetero Pharma Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 67. Teva Pharmaceutical pvt. Ltd. Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 68. Olainfarm JSC Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 69. Gilead Sciences, Inc. Revenue Growth Rate in Pediatric Influenza Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年）

Global Pediatric HIV Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児HIV感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（無症状、軽症、中症、重症）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、主要地域別市場規模（北米、...

世界の小児喘息治療市場規模・現状・予測（2021年-2027年）

Global Pediatric Asthma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4671 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、小児喘息治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（長期管理薬、即時解放薬、その他）、用途別市場規模（病院、クリニック、在宅治療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の犬インフルエンザ治療市場規模・現状・予測（2021年-2027年）

Global Canine Influenza Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3962 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、犬インフルエンザ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬（NSAID）、抗ウイルス薬、その他）、用途別市場規模（獣医クリニック、獣医薬局、オンライン薬局、そ...

世界の一般インフルエンザ診断市場規模・現状・予測（2021年-2027年）

Global General Influenza Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4250 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、一般インフルエンザ診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RIDT、ウイルス培養、DFA、血清学的アッセイ）、用途別市場規模（病院、臨床検査室、その他エンドユーザー）、主要地域別市場規模（...

世界の分子インフルエンザ検査市場規模・現状・予測（2021年-2027年）

Global Molecular Influenza Test Market Size, Status and Forecast 2021-2027
QFJ1-4525 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、分子インフルエンザ検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RT-PCR、TMA、LAMP、NASBA、その他）、用途別市場規模（病院、臨床検査室、その他）、主要地域別市場規模（北米、アメリ...

世界の小児硝子体手術市場規模・現状・予測（2021年-2027年）

Global Pediatric Vitrectomy Market Size, Status and Forecast 2021-2027
QFJ1-4677 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、小児硝子体手術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（毛様体扁平部硝子体切除術、前部硝子体切除術）、用途別市場規模（病院、眼科クリニック、外来手術センター、その他）、主要地域別市場規模（北米、...

世界の小児灌流システム市場規模・現状・予測（2021年-2027年）

Global Pediatric Perfusion System Market Size, Status and Forecast 2021-2027
QFJ1-5295 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、小児灌流システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小児用カニューレ、小児用遠心血液ポンプ、小児用動脈フィルター、血液濃縮器、HMSPlus止血管理システム）、用途別市場規模（病院、クリニ...

世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Influenza Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4366 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、インフルエンザ用抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、アダマンタン、その他）、用途別市場規模（病院、クリニック、外科医院、薬局、その他）、...

世界のインフルエンザ治療薬市場規模・現状・予測（2021年-2027年）

Global Influenza Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4367 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、インフルエンザ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、医薬品）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界のインフルエンザ用治療薬市場規模・現状・予測（2021年-2027年）

Global Influenza Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5802 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、インフルエンザ用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、...

世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Influenza Antiviral Drugs Market The global Influenza Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
世界の犬インフルエンザ治療市場規模・現状・予測（2021年-2027年） Canine influenza is also known as dog flu, and it is a contagious respiratory disease that spreads in an airborne and aerosolized manner in dogs, caused by Type A influenza viruses. Market Analysis and Insights: Global Canine Influenza Treatment Market The global Canine Influenza Treatment market s…
世界の小児喘息治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Asthma Treatment Market The global Pediatric Asthma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年） Antiviral drugs are a class of drugs for the specific treatment of viral infections. Market Analysis and Insights: Global Influenza (Flu) Antiviral Drugs Market The global Influenza (Flu) Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR…
世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年） Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF Market Analysis and Insights: Global Pediatric HIV Infection Treatment Market The global Pediatric HIV Infection Treatment market size i…